Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

GOS and the Management of Hyperuricemia

NCT06630377
completednot_applicable

Prebiotics and Mental Health: Behavioural

NCT04616937
completednot_applicable

The Effect of Feeding Infant Formula With Bimuno Galactooligosaccharide (GOS)

NCT02796872
completednot_applicable

Study to Evaluate the Tolerability of Prebiotics on the Microbiota

NCT02628652

Clinical Trials (4)

Showing 4 of 4 trials
NCT06630377Not Applicable

GOS and the Management of Hyperuricemia

Recruiting
NCT04616937Not Applicable

Prebiotics and Mental Health: Behavioural

Completed
NCT02796872Not Applicable

The Effect of Feeding Infant Formula With Bimuno Galactooligosaccharide (GOS)

Completed
NCT02628652Not Applicable

Study to Evaluate the Tolerability of Prebiotics on the Microbiota

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4